Monday, August 31, 2026

PennyMac Mortgage Investment Trust And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

September 29, 2023

PennyMac Mortgage Investment Trust  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - PennyMac Mortgage Investment Trust (PMT), Horizon Technology Finance Corporation (HRZN), National Health Investors (NHI) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. PennyMac Mortgage Investment Trust (PMT)

78.5% sales growth and 5.09% return on equity

PennyMac Mortgage Investment Trust, a specialty finance company, primarily invests in mortgage-related assets in the United States. It operates through four segments: Credit Sensitive Strategies, Interest Rate Sensitive Strategies, Correspondent Production, and Corporate. The company's Credit Sensitive Strategies segment invests in credit risk transfer (CRT) agreements, CRT securities, distressed loans, real estate, and non-agency subordinated bonds. Its Interest Rate Sensitive Strategies segment engages in investing in mortgage servicing rights, excess servicing spreads, and agency and senior non-agency mortgage-backed securities (MBS), as well as related interest rate hedging activities. The company's Correspondent Production segment is involved in purchasing, pooling, and reselling newly originated prime credit residential loans directly or in the form of MBS. PNMAC Capital Management, LLC acts as the manager of PennyMac Mortgage Investment Trust. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its shareholders. PennyMac Mortgage Investment Trust was founded in 2009 and is headquartered in Westlake Village, California.

Earnings Per Share

As for profitability, PennyMac Mortgage Investment Trust has a trailing twelve months EPS of $0.61.

PE Ratio

PennyMac Mortgage Investment Trust has a trailing twelve months price to earnings ratio of 20.38. Meaning, the purchaser of the share is investing $20.38 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.09%.

2. Horizon Technology Finance Corporation (HRZN)

23.1% sales growth and 4.79% return on equity

Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries. It seeks to invest in companies in the United States.

Earnings Per Share

As for profitability, Horizon Technology Finance Corporation has a trailing twelve months EPS of $0.57.

PE Ratio

Horizon Technology Finance Corporation has a trailing twelve months price to earnings ratio of 20.72. Meaning, the purchaser of the share is investing $20.72 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.79%.

3. National Health Investors (NHI)

11.5% sales growth and 8.04% return on equity

Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Earnings Per Share

As for profitability, National Health Investors has a trailing twelve months EPS of $2.53.

PE Ratio

National Health Investors has a trailing twelve months price to earnings ratio of 20.28. Meaning, the purchaser of the share is investing $20.28 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.04%.

Moving Average

National Health Investors's value is below its 50-day moving average of $52.37 and under its 200-day moving average of $53.05.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Sep 27, 2023, the estimated forward annual dividend rate is 3.6 and the estimated forward annual dividend yield is 7.08%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 29.4%, now sitting on 307.23M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

National Health Investors's EBITDA is 10.82.

4. Universal Health Services (UHS)

6.1% sales growth and 11.27% return on equity

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Earnings Per Share

As for profitability, Universal Health Services has a trailing twelve months EPS of $9.62.

PE Ratio

Universal Health Services has a trailing twelve months price to earnings ratio of 13.32. Meaning, the purchaser of the share is investing $13.32 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.27%.

Moving Average

Universal Health Services's worth is under its 50-day moving average of $134.88 and under its 200-day moving average of $138.00.

Yearly Top and Bottom Value

Universal Health Services's stock is valued at $128.12 at 16:22 EST, way below its 52-week high of $158.57 and way above its 52-week low of $82.50.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Aug 30, 2023, the estimated forward annual dividend rate is 0.8 and the estimated forward annual dividend yield is 0.63%.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com